On September 8, 2020 Imago BioSciences, Inc. ("Imago"), a private clinical stage biopharmaceutical company developing innovative treatments for myeloid diseases, reported that Hugh Young Rienhoff, Jr. M.D., chief executive officer, will present a corporate overview at two upcoming investor conferences (Press release, Imago BioSciences, SEP 8, 2020, View Source [SID1234564710]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Citi’s 15th Annual BioPharma Virtual Conference
Date: Tuesday, September 8th 2020
Time: 2:20 p.m. ET
Logistics: If you’d like to register and attend the company presentation, click here to learn more.
H.C. Wainwright 22nd Annual Global Investment Virtual Conference
Date: Monday, September 14th 2020
Time: 10:00 a.m. ET
Logistics: If you’d like to register and attend the company presentation, click here to learn more.